BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10861815)

  • 21. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
    Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
    J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.
    Medeiros LJ; Hai S; Thomazy VA; Estalilla OC; Romaguera J; Luthra R
    Mod Pathol; 2002 May; 15(5):556-64. PubMed ID: 12011261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
    Tiemann M; Schrader C; Klapper W; Dreyling MH; Campo E; Norton A; Berger F; Kluin P; Ott G; Pileri S; Pedrinis E; Feller AC; Merz H; Janssen D; Hansmann ML; Krieken H; Möller P; Stein H; Unterhalt M; Hiddemann W; Parwaresch R;
    Br J Haematol; 2005 Oct; 131(1):29-38. PubMed ID: 16173960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell levels are prognostic in mantle cell lymphoma.
    Nygren L; Wasik AM; Baumgartner-Wennerholm S; Jeppsson-Ahlberg Å; Klimkowska M; Andersson P; Buhrkuhl D; Christensson B; Kimby E; Wahlin BE; Sander B
    Clin Cancer Res; 2014 Dec; 20(23):6096-104. PubMed ID: 25294911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL).
    Callea V; Clò V; Morabito F; Baldini L; Stelitano C; Narni F; Avanzini P; Brugiatelli M; Silingardi V
    Haematologica; 1998 Nov; 83(11):993-7. PubMed ID: 9864919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic diagnosis of mantle cell lymphoma.
    Lai R; Medeiros LJ
    Clin Lymphoma; 2000 Dec; 1(3):197-206; discussion 207-8. PubMed ID: 11707830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
    Weisenburger DD
    Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.
    Bhatt VR; Loberiza FR; Smith LM; Armitage JO; Greiner TC; Bast M; Lunning MA; Bierman PJ; Vose JM; Bociek RG
    Leuk Lymphoma; 2016; 57(6):1327-34. PubMed ID: 26377137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splenic involvement by blastic mantle cell lymphoma (large cell/anaplastic variant) mimicking splenic marginal zone lymphoma.
    Mollejo M; Lloret E; Solares J; Bergua JM; Mateo M; Piris MA
    Am J Hematol; 1999 Dec; 62(4):242-6. PubMed ID: 10589081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
    Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results from the Belgian mantle cell lymphoma registry.
    Vergote V; Janssens A; André M; Bonnet C; Van Hende V; Van Den Neste E; Van Eygen K; Maerevoet M; Pranger D; Schroyens W; Debussche S; Maertens V; Beel K; Lemmens J; Caron C; Delrieu V; Van Den Broeck I; Vanstraelen G; Jacquy C; Schauvlieghe L; De Samblanx H; Madoe V; Meers S; Boulet D; Verhoef G; Van Hoof A
    Acta Clin Belg; 2017 Jun; 72(3):172-178. PubMed ID: 28222652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
    Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO;
    Leuk Lymphoma; 2003 Nov; 44(11):1903-10. PubMed ID: 14738141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Follicular and mantle cell lymphoma diagnosed in biopsies of gastroenterocolic region].
    Plank L; Balhárek T; Szépe P
    Cesk Patol; 2016; 52(1):31-9. PubMed ID: 27108554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathologic diagnosis of mantle cell lymphoma based on histologic, cytologic, immunohistologic and genetic characteristics].
    László T; Csernus B; Krenács L; Kelényi G; Matolcsy A
    Orv Hetil; 1999 Dec; 140(52):2907-12. PubMed ID: 10659642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].
    Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
    Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
    Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.
    Bosch F; López-Guillermo A; Campo E; Ribera JM; Conde E; Piris MA; Vallespí T; Woessner S; Montserrat E
    Cancer; 1998 Feb; 82(3):567-75. PubMed ID: 9452276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of LATS mRNA in mantle cell lymphoma and its clinical significance].
    Yu Z; Yi S; Zhang Y; Li Z; Qiu L
    Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(40):3285-8. PubMed ID: 26815349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.